Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Reslizumab in patients with inadequately controlled late-onset asthma and elevated blood eosinophils.

Brusselle G, Germinaro M, Weiss S, Zangrilli J.

Pulm Pharmacol Ther. 2017 Apr;43:39-45. doi: 10.1016/j.pupt.2017.01.011. Epub 2017 Jan 31.

2.

Reslizumab for Inadequately Controlled Asthma With Elevated Blood Eosinophil Levels: A Randomized Phase 3 Study.

Bjermer L, Lemiere C, Maspero J, Weiss S, Zangrilli J, Germinaro M.

Chest. 2016 Oct;150(4):789-798. doi: 10.1016/j.chest.2016.03.032. Epub 2016 Apr 4.

3.

Association of B-cell activating factor receptor deficiency with the P21R polymorphism and common variable immunodeficiency.

Germinaro M, Reynolds P, Knight V, Alam R.

Ann Allergy Asthma Immunol. 2015 Jul;115(1):82-3. doi: 10.1016/j.anai.2015.04.020. Epub 2015 May 23. No abstract available.

4.

Aberrant Wnt/beta-catenin signaling in pancreatic adenocarcinoma.

Zeng G, Germinaro M, Micsenyi A, Monga NK, Bell A, Sood A, Malhotra V, Sood N, Midda V, Monga DK, Kokkinakis DM, Monga SP.

Neoplasia. 2006 Apr;8(4):279-89.

5.

beta-Catenin regulation during matrigel-induced rat hepatocyte differentiation.

Monga SP, Micsenyi A, Germinaro M, Apte U, Bell A.

Cell Tissue Res. 2006 Jan;323(1):71-9. Epub 2005 Sep 14.

PMID:
16160859

Supplemental Content

Loading ...
Support Center